Patrick Baeuerle
Biotech entrepreneur and scientist focused on T-cell engagers and bispecific antibodies; co-founder and chief scientific advisor at Cullinan Therapeutics with a history of developing CD19-CD3 bispecifics and multiple biotech startups.
Best podcasts with Patrick Baeuerle
Ranked by the Snipd community
Mar 17, 2026 • 59min
Episode: 83 - Patrick Baeuerle and Jeffrey Miller on T Cell and Immune Cell Engagement
Jeffrey Miller, physician‑scientist advancing NK cell therapies and tri‑specific NK engagers. Patrick Baeuerle, biotech entrepreneur behind T‑cell bispecifics and peptide‑MHC work. They compare T cell and NK engagers to CAR T approaches. Topics include conditional tumor selectivity, IL‑15 and NK activation, peptide‑MHC targeting, manufacturing and clinical strategies, and use in MRD and neoadjuvant settings.
